Katty Kang’s research is focused on understanding the pathophysiology of the GABAA receptor mutation associated with two common childhood neurological disorders: epilepsy and autism. Both disorders impair typical brain development, cause long-term disability, and are without cure. Her research goal is to elucidate the underpinning molecular mechanisms of the two disorders and find better therapeutic options to attenuate or eliminate the phenotypes, thereby improving the learning ability and the quality of life of children who have these disorders.